Related Experiment Video
Updated: Jun 6, 2026

07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
The revised tumor-node-metastasis staging system for lung cancer: changes and perspectives
Filipe Moreira de Andrade1, Omar Moté Abou Mourad, Luiz Felippe Judice
1Antonio Pedro University Hospital – Fluminense Federal University – School of Medicine, Niterói, Brazil. filipeandrade_torax@hotmail.com
Summary
The tumor-node-metastasis (TNM) staging system for lung cancer has been updated, with the seventh edition incorporating worldwide data. Future revisions may include molecular aspects for more precise lung cancer staging.
Area of Science:
- Oncology
- Medical Diagnostics
- Cancer Research
Background:
- The tumor-node-metastasis (TNM) staging system is crucial for lung cancer classification.
- Previous TNM editions have undergone modifications since their inception.
- The seventh edition represents a significant update based on extensive global data.
Purpose of the Study:
- To analyze the impact of the seventh edition of the TNM staging system for lung cancer.
- To identify areas for future refinement in lung cancer staging.
- To explore the potential inclusion of molecular markers in upcoming TNM revisions.
Main Methods:
- Analysis of a comprehensive, worldwide database for lung cancer staging.
- Evaluation of changes in tumor and metastasis descriptors in the seventh TNM edition.
- Review of node descriptor recommendations and future trends.
Main Results:
- Significant modifications were implemented in the tumor and metastasis descriptors for lung cancer.
- Node descriptor recommendations remained unchanged in the seventh edition but are subject to future updates.
- The analysis indicates a trend towards incorporating molecular aspects into future TNM staging.
Conclusions:
- The seventh edition of the TNM staging system for lung cancer reflects substantial global data analysis.
- Future TNM staging revisions are anticipated to evolve, potentially integrating molecular insights.
- Enhanced lung cancer staging aims for greater precision and improved patient management.
